Bing Lim

Merck & Co., Inc.

United States

  • Merck & Co., Inc.

SCHOLARLY PAPERS

1

DOWNLOADS

11

SSRN CITATIONS

1

CROSSREF CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Immune Cell Phenotypes that Determine Disease Severity and Long-Term Neutralizing Antibody Titers after Natural Dengue Virus Infection

Number of pages: 79 Posted: 17 Apr 2020
Angeline Rouers, Melissa Chng, Bernett Lee, Menaka P. Rajapakse, Kaval Kaur, Ying Xiu Toh, Durgalakshmi Sathiakumar, Yee Sin Leo, Kalpit Vora, Danilo Casimiro, Bing Lim, Lisa Tucker-Kellogg, Laura Rivino, Evan W. Newell and Katja Fink
Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), National Centre for Infectious Diseases, Merck & Co., Inc., Merck & Co., Inc., Merck & Co., Inc., Duke-NUS Graduate Medical School Singapore, Duke-NUS Medical School - Emerging Infectious Diseases Programme, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division and Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN)
Downloads 11 (896,463)
Citation 1

Abstract:

Loading...

Dengue, T cell, B cell, Longitudinal, Disease Severity, Antibodies, Correlates of Protection